194 related articles for article (PubMed ID: 27012201)
41. Depletion of end-binding protein 1 (EB1) promotes apoptosis of human non-small-cell lung cancer cells via reactive oxygen species and Bax-mediated mitochondrial dysfunction.
Kim MJ; Yun HS; Hong EH; Lee SJ; Baek JH; Lee CW; Yim JH; Kim JS; Park JK; Um HD; Hwang SG
Cancer Lett; 2013 Oct; 339(1):15-24. PubMed ID: 23900080
[TBL] [Abstract][Full Text] [Related]
42. [P53 protein expression and chemosensitivity to cisplatin in patients with non-small cell lung cancer: a meta-analysis].
Wang JL; Jiao SC; Ye P; Li JY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):770-3. PubMed ID: 18504201
[TBL] [Abstract][Full Text] [Related]
43. Chimeric ubiquitin ligases inhibit non-small cell lung cancer via negative modulation of EGFR signaling.
Zhong D; Ru Y; Wang Q; Zhang J; Zhang J; Wei J; Wu J; Yao L; Li X; Li X
Cancer Lett; 2015 Apr; 359(1):57-64. PubMed ID: 25573345
[TBL] [Abstract][Full Text] [Related]
44. TRIM65 regulates microRNA activity by ubiquitination of TNRC6.
Li S; Wang L; Fu B; Berman MA; Diallo A; Dorf ME
Proc Natl Acad Sci U S A; 2014 May; 111(19):6970-5. PubMed ID: 24778252
[TBL] [Abstract][Full Text] [Related]
45. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
[TBL] [Abstract][Full Text] [Related]
46. PDL1 Regulation by p53 via miR-34.
Cortez MA; Ivan C; Valdecanas D; Wang X; Peltier HJ; Ye Y; Araujo L; Carbone DP; Shilo K; Giri DK; Kelnar K; Martin D; Komaki R; Gomez DR; Krishnan S; Calin GA; Bader AG; Welsh JW
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26577528
[TBL] [Abstract][Full Text] [Related]
47. LIMCH1 suppress the growth of lung cancer by interacting with HUWE1 to sustain p53 stability.
Zhang Y; Zhang Y; Xu H
Gene; 2019 Sep; 712():143963. PubMed ID: 31279706
[TBL] [Abstract][Full Text] [Related]
48. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
[TBL] [Abstract][Full Text] [Related]
49. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
[TBL] [Abstract][Full Text] [Related]
50. TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ.
Qin X; Qiu F; Zou Z
Biochem Biophys Res Commun; 2017 Nov; 493(1):568-572. PubMed ID: 28867193
[TBL] [Abstract][Full Text] [Related]
51. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
[TBL] [Abstract][Full Text] [Related]
52. Smurf1 ubiquitin ligase targets Kruppel-like factor KLF2 for ubiquitination and degradation in human lung cancer H1299 cells.
Xie P; Tang Y; Shen S; Wang Y; Xing G; Yin Y; He F; Zhang L
Biochem Biophys Res Commun; 2011 Apr; 407(1):254-9. PubMed ID: 21382345
[TBL] [Abstract][Full Text] [Related]
53. Smurf2 regulates the degradation of YY1.
Jeong HM; Lee SH; Yum J; Yeo CY; Lee KY
Biochim Biophys Acta; 2014 Sep; 1843(9):2005-11. PubMed ID: 24803334
[TBL] [Abstract][Full Text] [Related]
54. Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.
Abedini MR; Muller EJ; Bergeron R; Gray DA; Tsang BK
Oncogene; 2010 Jan; 29(1):11-25. PubMed ID: 19802016
[TBL] [Abstract][Full Text] [Related]
55. HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.
Yang D; Cheng D; Tu Q; Yang H; Sun B; Yan L; Dai H; Luo J; Mao B; Cao Y; Yu X; Jiang H; Zhao X
Theranostics; 2018; 8(13):3517-3529. PubMed ID: 30026863
[TBL] [Abstract][Full Text] [Related]
56. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
[TBL] [Abstract][Full Text] [Related]
57. CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53-mediated trans-repression of β-secretase.
Singh AK; Pati U
Aging Cell; 2015 Aug; 14(4):595-604. PubMed ID: 25773675
[TBL] [Abstract][Full Text] [Related]
58. TRIM45 functions as a tumor suppressor in the brain via its E3 ligase activity by stabilizing p53 through K63-linked ubiquitination.
Zhang J; Zhang C; Cui J; Ou J; Han J; Qin Y; Zhi F; Wang RF
Cell Death Dis; 2017 May; 8(5):e2831. PubMed ID: 28542145
[TBL] [Abstract][Full Text] [Related]
59. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
60. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]